← Back
Data updated: Mar 10, 2026
LNK
Pharmaceuticals
LNK is a generic drug manufacturer with 5 FDA-approved products.
1983
Since
5
Drugs
-
Trials
112
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
LOPERAMIDE HYDROCHLORIDE 2025-12-29
LOPERAMIDE HYDROCHLORIDE 2025-11-17
DIPHENHYDRAMINE HYDROCHLORIDE 2025-11-14
LOPERAMIDE HYDROCHLORIDE 2025-09-19
DIPHENHYDRAMINE HYDROCHLORIDE 2025-08-22
METRONIDAZOLE 2025-07-09
DIPHENHYDRAMINE HYDROCHLORIDE 2025-06-24
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (3)
Company Info
- First Approval
- 1983-01-27
- Latest
- 2025-03-20
- Applications
- 8